SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-11-009301
Filing Date
2011-11-09
Accepted
2011-11-09 16:03:16
Documents
13
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2206194z10-q.htm 10-Q 549764
2 EX-10.1 a2206194zex-10_1.htm EX-10.1 666569
3 EX-31.1 a2206194zex-31_1.htm EX-31.1 8659
4 EX-31.2 a2206194zex-31_2.htm EX-31.2 8662
5 EX-32.1 a2206194zex-32_1.htm EX-32.1 9594
12 G279893KG01I001.JPG g279893kg01i001.jpg GRAPHIC 4357
13 G279893KG01I002.JPG g279893kg01i002.jpg GRAPHIC 119948
  Complete submission text file 0001047469-11-009301.txt   3236856

Data Files

Seq Description Document Type Size
6 EX-101.INS astx-20110930.xml EX-101.INS 278819
7 EX-101.SCH astx-20110930.xsd EX-101.SCH 15399
8 EX-101.CAL astx-20110930_cal.xml EX-101.CAL 43747
9 EX-101.DEF astx-20110930_def.xml EX-101.DEF 72822
10 EX-101.LAB astx-20110930_lab.xml EX-101.LAB 231094
11 EX-101.PRE astx-20110930_pre.xml EX-101.PRE 108187
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
Astex Pharmaceuticals, Inc (Filer) CIK: 0000919722 (see all company filings)

IRS No.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27628 | Film No.: 111191709
SIC: 2834 Pharmaceutical Preparations